52 related articles for article (PubMed ID: 11135013)
1. Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice.
Hutcheson DM; Matthes HW; Valjent E; Sánchez-Blázquez P; Rodríguez-Díaz M; Garzón J; Kieffer BL; Maldonado R
Eur J Neurosci; 2001 Jan; 13(1):153-61. PubMed ID: 11135013
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
3. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
4. Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice.
Ghozland S; Chu K; Kieffer BL; Roberts AJ
Neuropharmacology; 2005 Sep; 49(4):493-501. PubMed ID: 15961126
[TBL] [Abstract][Full Text] [Related]
5. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
Robledo P; Mendizabal V; Ortuño J; de la Torre R; Kieffer BL; Maldonado R
Eur J Neurosci; 2004 Aug; 20(3):853-8. PubMed ID: 15255997
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
Sánchez-Blázquez P; García-Espãna A; Garzón J
J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
Berrendero F; Kieffer BL; Maldonado R
J Neurosci; 2002 Dec; 22(24):10935-40. PubMed ID: 12486188
[TBL] [Abstract][Full Text] [Related]
8. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
9. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
10. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
[TBL] [Abstract][Full Text] [Related]
11. Mu opioid receptor-dependent and independent components in effects of tramadol.
Ide S; Minami M; Ishihara K; Uhl GR; Sora I; Ikeda K
Neuropharmacology; 2006 Sep; 51(3):651-8. PubMed ID: 16793069
[TBL] [Abstract][Full Text] [Related]
12. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
Hall FS; Goeb M; Li XF; Sora I; Uhl GR
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
[TBL] [Abstract][Full Text] [Related]
13. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice.
Li SR; Wang T; Wang R; Dai X; Chen Q; Li RD
Brain Res; 2005 May; 1043(1-2):132-8. PubMed ID: 15862526
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
15. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice.
Dai X; Cui SG; Li SR; Chen Q; Wang R
Behav Brain Res; 2007 Aug; 182(1):21-7. PubMed ID: 17568695
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T
Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924
[TBL] [Abstract][Full Text] [Related]
20. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
